Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results".

ABSTRACT:

SUBMITTER: Muhlbacher AC 

PROVIDER: S-EPMC7891755 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature